抗菌薬感受性試験市場- 世界の産業規模、動向、競合、機会、予測、2018年-2028年製品別、技術別、用途別、エンドユーザー別、地域別、競合

抗菌薬感受性試験（Antimicrobial Susceptibility Testing：AST）とは、分離された細菌や真菌の様々な抗菌薬に対する感受性や耐性を調べるために用いられる検査法です。

インビトロ抗菌薬感受性試験は、ディスク拡散法、寒天希釈法、ブロス微量希釈法、ブロスマクロ希釈法、濃度勾配試験など、さまざまな種類の形式を用いて実施することができます。抗菌薬感受性試験（AST）の結果は、患者に対する適切な抗菌薬療法の選択の指針となります。感受性試験の結果は、最小発育阻止濃度（MIC）として報告されます。MICは、菌の発育を阻止する抗菌薬の最低濃度です。MIC値を用いて、その菌が抗菌薬に対して感受性であるか、中間的であるか、あるいは耐性であるかといったいくつかの特徴を判定することができます。世界保健機関（WHO）の報告によると、抗菌薬耐性は世界の健康にとって重大な脅威であり、2050年までにはがんよりも多くの死者を出す可能性があると推定されています。抗菌薬感受性検査市場は、感染症の流行増加によって牽引されています。赤痢菌、淋菌、髄膜炎菌、サルモネラ腸炎菌のようないくつかの感染症の発生は、水の供給、衛生、衛生の欠如に起因しており、予測期間中に抗菌薬感受性試験の需要を高めています。さらに、国の様々な地域における老年人口の増加は、インフルエンザ、肺炎、帯状疱疹、その他、老年期に関連する特定の種類の疾患とともに、予測期間における世界の抗菌薬感受性検査市場の成長をさらに促進すると予想されます。

感染症の有病率の増加

感染症は、細菌、ウイルス、真菌、寄生虫、プリオンなどの病原性微生物によって引き起こされるある種の疾患です。これらの微生物は人体に侵入し、増殖し、組織を傷つけたり、毒素を分泌したり、免疫反応を引き起こして炎症を起こしたりすることによって病気を引き起こします。インフルエンザ、マラリア、結核、デング熱などは、世界中で最も一般的に流行している感染症です。抗菌薬感受性試験は、感染症に対する適切な抗菌薬療法を決定するための重要なツールです。患者が感染症に罹患すると、細菌のサンプルが採取され、抗菌薬感受性試験のために検査室に送られます。検査で得られた結果は、患者の感染症を治療するための適切な抗菌薬の選択に使用されます。最近では、SARS-CoV-2ウイルスによるCOVID-19パンデミックが、世界中の多くの人々に影響を与える主要な感染症として浮上しています。Worldometerが2023年に発表した報告書によると、2021年には米国でCOVID-19が106,771,290件報告され、1,162,471人が死亡、次いでインドでCOVID-19が44,971,469件報告され、531,692人が死亡、フランスでCOVID-19が40,021,949件報告され、166,811人が死亡、などとなっています。肺炎は、世界中のさまざまな発展途上国で蔓延している感染症の中で2番目に多いです。ユニセフが2019年に発表した報告書によると、肺炎は他のどの感染症よりも多くの子どもたちを死亡させており、毎年70万人以上、毎日約2000人の5歳未満の子どもたちの命を奪っていると結論付けられています。この中には20万人以上の新生児も含まれています。世界全体では、子ども10万人当たり1,400人以上、つまり毎年子ども71人当たり1人の割合で肺炎が発生しており、発生率が最も高いのは南アジア（子ども10万人当たり2,500人）と西・中央アフリカ（子ども10万人当たり1,620人）です。さらに、これらの疾患の予防を目的とした抗菌薬感受性検査への依存度が高まっていることから、予測期間において世界の抗菌薬感受性検査市場は目覚ましい成長を遂げると予想されます。

老人人口の増加

世界各地における高齢者人口の増加も、予測期間における世界の抗菌薬感受性試験市場の重要な促進要因の1つです。高齢者人口は感染症にかかりやすく、免疫力が低下しているため細菌感染にかかりやすいからです。ヘルスケアと医療技術の向上により、高齢者の平均寿命が延び、その結果、体内の感染症の発症を早期に食い止めるために、高齢者の間で抗菌薬感受性検査の需要が高まっています。インフルエンザ、帯状疱疹、結核、胃腸感染症、尿路感染症などは、65歳以降に発症する疾病の一部です。人口問題研究所（PRB）が発表した世界最高齢人口国に基づく報告書によると、総人口に占める老人人口の割合は、日本が約28.2％で世界一、次いでイタリアが22.8％、ギリシャ、ポルトガルが21.8％、ドイツが21.4％となっています。今後、世界中の様々な新興諸国における老人人口の比率の増加や、高齢期の人々に関連する疾患の有病率の増加も、今後数年間の世界の抗菌薬感受性試験市場の成長を後押しすると予想されます。

調査範囲

本レポートでは、世界の抗菌薬感受性検査市場を以下のカテゴリーに分類し、さらに業界動向についても詳述しています。

抗菌薬感受性試験市場、製品別

• 手動検査（MICストリップ、感受性試験ディスク、感受性プレート）
• 自動機器
• 消耗品および培地

抗菌薬感受性試験市場：技術別

• 自動AST
• 試験法
• 希釈法
• ディスク拡散法
• その他

抗菌薬感受性試験市場：用途別

• 医薬品開発
• 感受性試験
• その他

抗菌薬感受性試験市場：エンドユーザー別

• 病院
• 診断研究所
• バイオテクノロジー・製薬会社
• その他

抗菌薬感受性試験市場：地域別

• 北米
• 米国
• カナダ
• メキシコ
• アジア太平洋
• 中国
• インド
• 韓国
• オーストラリア
• 日本
• 欧州
• ドイツ
• フランス
• 英国
• スペイン
• イタリア
• 南米
• ブラジル
• アルゼンチン
• コロンビア
• 中東＆アフリカ
• 南アフリカ
• サウジアラビア
• アラブ首長国連邦

競合情勢

• 企業プロファイル：世界の抗菌薬感受性試験市場における主要企業の詳細分析

利用可能なカスタマイズ：

• TechSci Research社は、所定の市場データを用いて、企業固有のニーズに応じたカスタマイズを提供します。レポートでは以下のカスタマイズが可能です：

企業情報

• 追加市場参入企業（最大5社）の詳細分析とプロファイリング

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 抗菌薬感受性試験の世界市場展望

• 市場規模・予測
  • 金額・数量別
• 市場シェアと予測
  • 製品別（手動検査、（MICストリップ、感受性試験ディスク、感受性プレート）自動化機器、消耗品＆培地）
  • 手法別（自動AST、Etest法、希釈法、ディスク拡散法、その他）
  • アプリケーション別（医薬品開発、感受性試験、その他）
  • エンドユーザー別（病院、診断研究所、バイオテクノロジー・製薬会社、その他）
  • 地域別
  • 企業別（2022年）
• 製品市場マップ

第6章 北米の抗菌薬感受性試験市場展望

• 市場規模・予測
  • 金額・数量別
• 市場シェアと予測
  • 製品別
  • 技術別
  • 用途別
  • エンドユーザー別
  • 国別
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第7章 欧州の抗菌薬感受性試験市場の展望

• 市場規模・予測
  • 金額・数量別
• 市場シェアと予測
  • 製品別
  • 技術別
  • 用途別
  • エンドユーザー別
  • 国別
• 欧州国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋地域の抗菌薬感受性試験市場の展望

• 市場規模・予測
  • 金額・数量別
• 市場シェアと予測
  • 製品別
  • 技術別
  • 用途別
  • エンドユーザー別
  • 国別
• アジア太平洋地域国別分析
  • 中国
  • インド
  • 韓国
  • 日本
  • オーストラリア

第9章 南米の抗菌薬感受性試験市場の展望

• 市場規模・予測
  • 金額・数量別
• 市場シェアと予測
  • 製品別
  • 技術別
  • 用途別
  • エンドユーザー別
  • 国別
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカ抗菌薬感受性試験市場の展望

• 市場規模・予測
  • 金額・数量別
• 市場シェアと予測
  • 製品別
  • 技術別
  • 用途別
  • エンドユーザー別
  • 国別
• MEA：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

第13章 PESTLE分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 競合情勢

• Business Overview
• Company Snapshot
• Products & Services
• Financials（In case of listed companies）
• Recent Developments
• SWOT Analysis
  • Bio-Rad Laboratories Inc.
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • bioMerieux, Inc.
  • Creative Diagnostics
  • Hi-Media Laboratories Pvt. Ltd.
  • PerkinElmer, Inc.
  • ELITech Group SAS
  • F. Hoffmann-La Roche Ltd.
  • Accelerate Diagnostics, Inc.

第16章 戦略的提言

第17章 調査会社について・免責事項

Antimicrobial susceptibility testing (AST) is a laboratory procedure used to determine the susceptibility or resistance of a bacterial or fungal isolate to various antimicrobial agents. In-vitro antimicrobial susceptibility testing can be performed using various type of formats such as disk diffusion, agar dilution, broth microdilution, broth macrodilution, and a concentration gradient test. The results of Antimicrobial Susceptibility Testing (AST) are used to guide the choice of appropriate antimicrobial therapy for the patient. Susceptibility results are reported as the minimum inhibitory concentration (MIC), which is the lowest concentration of the antimicrobial agent that inhibits the growth of the organism. Several characteristics such as whether the organism is susceptible, intermediate, or resistant to the antimicrobial agent can be determined using MIC values. According to a report by the World Health Organization (WHO), antimicrobial resistance is a significant threat to global health, and it is estimated that by 2050, it could cause more deaths than cancer. The market for antimicrobial susceptibility testing is driven by the increase in prevalence of infectious diseases. Several infectious disease outbreaks such as Shigella, Neisseria gonorrhoeae, Neisseria meningitides, and Salmonella serotype typhi which has been attributed to lack of water supply, sanitation, and hygiene are rising the demand for antimicrobial susceptibility testing in the forecast period. Moreover, increase in geriatric population across various parts of the country along with certain type of diseases influenza, pneumonia, shingles, and others which are associated with them in their elder age is further expected to propel the growth of global antimicrobial susceptibility testing market in the forecast period.

Increase in Prevalence of Infectious Diseases

Infectious diseases are certain kind of disorders caused by pathogenic microorganisms, such as bacteria, viruses, fungi, parasites, and prions. These microorganisms can invade the human body, multiply, and cause disease by damaging tissues, secreting toxins, or triggering an immune response that results in inflammation. Influenza, malaria, tuberculosis, dengue, and others are some of the most commonly prevailing infectious diseases across the world. Antimicrobial susceptibility testing is a critical tool for determining the appropriate antimicrobial therapy for infectious diseases. When a patient gets affected with infectious disease, sample of the bacteria is taken and is sent to the laboratory for antimicrobial susceptibility testing. Results obtained from the test are used to guide the selection of an appropriate antibiotic for treating the patient's infection. In recent times, COVID-19 pandemic caused by the SARS-CoV-2 virus have emerged as the leading infectious disease affecting many people across the world. According to the report published by Worldometer in 2023, it has been observed that in 2021 around 106,771,290 cases of COVID-19 were reported in United States of America causing 1,162,471 deaths, followed by 44,971,469 cases of COVID-19 in India causing 531,692 deaths, 40,021,949 cases of COVID-19 in France leading to 166,811 deaths, and so on. Pneumonia is the second most common infectious diseases prevailing in various developing countries across the world. As per the report presented by UNICEF in 2019, it has been concluded that pneumonia kills more children than any other infectious disease, claiming the lives of over 700,000 children under five every year, or around 2,000 every day. This includes over 200,000 newborns. Globally, there are over 1,400 cases of pneumonia per 100,000 children, or 1 case per 71 children every year, with the greatest incidence occurring in South Asia (2,500 cases per 100,000 children) and West and Central Africa (1,620 cases per 100,000 children). Moreover, growing dependence of people on antimicrobial susceptibility testing for prevention of these diseases is further expected to register an impressive growth to global antimicrobial susceptibility testing market in the forecast period.

Growth in Geriatric Population

Growth in geriatric population across various parts of the world is also one of the significant drivers of global antimicrobial susceptibility testing market in the forecast period. This is because the elderly population is more vulnerable to infectious diseases, and their weakened immune systems make them more susceptible to bacterial infections. Improvement in healthcare and medical technology have led to longer life expectancies among geriatric people which is thereby growing the demand of antimicrobial susceptibility testing among them to stop the development of infection in their body at early stage. Influenza, shingles, tuberculosis, gastrointestinal infections, and urinary tract infections are some of the diseases which effects most of the people after 65 years of age. According to the report published by Population Reference Bureau (PRB) based on countries with the oldest populations in the world, it has been concluded that Japan is the foremost country in the world accounting for around 28.2% of geriatric people out of total population, followed by Italy with 22.8% of geriatric population, Greece, and Portugal with 21.8 %, and Germany with 21.4% of geriatric people out of the total population. Henceforth, growing ratio of geriatric population in various developing countries across the globe and growing prevalence of diseases associated with people during their elder age is also expected to bolster the growth of global antimicrobial susceptibility testing market in upcoming years.

Market Segmentation

The global antimicrobial susceptibility testing market is segmented based on product, technique, application, end user, company, and region. In terms of product, the antimicrobial susceptibility testing market is categorized into manual tests, (MIC strips, susceptibility testing disks, susceptibility plates), automated instruments, and consumables & media. Based on technique, global antimicrobial susceptibility testing market is fragmented into automated AST, Etest method, dilution, disk diffusion, and others. Based on, application market is segmented into drug development, susceptibility testing, and others. Based on end user, global antimicrobial susceptibility testing market is fragmented into hospitals, diagnostic laboratories, biotechnique & pharmaceutical companies, and others.

Market Players

Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Danaher Corporation, bioMerieux, Inc., Creative Diagnostics, Hi-Media Laboratories Pvt. Ltd., PerkinElmer, Inc., ELITech Group SAS, F. Hoffmann-La Roche Ltd., and Accelerate Diagnostics, Inc. are some of the key players in the global antimicrobial susceptibility testing market.

Report Scope:

In this report, global antimicrobial susceptibility testing market has been segmented into following categories, in addition to the industry trends which have also been detailed below.

Antimicrobial Susceptibility Testing Market, By Product:

• Manual Tests (MIC Strips, Susceptibility Testing Disks, Susceptibility Plates)
• Automated Instruments
• Consumables & Media

Antimicrobial Susceptibility Testing Market, By Technique:

• Automated AST
• Etest Method
• Dilution
• Disk Diffusion
• Others

Antimicrobial Susceptibility Testing Market, By Application:

• Drug Development
• Susceptibility Testing
• Others

Antimicrobial Susceptibility Testing Market, By End User:

• Hospitals
• Diagnostic Laboratories
• BioTechnique & Pharmaceutical Companies
• Others

Antimicrobial Susceptibility Testing Market, By region:

• North America
• United States
• Canada
• Mexico
• Asia-Pacific
• China
• India
• South Korea
• Australia
• Japan
• Europe
• Germany
• France
• United Kingdom
• Spain
• Italy
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

• Company Profiles: Detailed analysis of the major companies present in global antimicrobial susceptibility testing market.

Available Customizations:

• With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Antimicrobial Susceptibility Testing Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value & Volume
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Manual Tests, (MIC Strips, Susceptibility Testing Disks, Susceptibility Plates) Automated Instruments, Consumables & Media)
  • 5.2.2. By Technique (Automated AST, Etest Method, Dilution, Disk Diffusion, Others)
  • 5.2.3. By Application (Drug Development, Susceptibility Testing, Others)
  • 5.2.4. By End User (Hospitals, Diagnostic Laboratories, BioTechnique & Pharmaceutical Companies, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2022)
• 5.3. Product Market Map

6. North America Antimicrobial Susceptibility Testing Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value & Volume
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Technique
  • 6.2.3. By Application
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Antimicrobial Susceptibility Testing Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value & Volume
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Technique
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End User
  • 6.3.2. Mexico Antimicrobial Susceptibility Testing Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value & Volume
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Technique
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End User
  • 6.3.3. Canada Antimicrobial Susceptibility Testing Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value & Volume
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Technique
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End User

7. Europe Antimicrobial Susceptibility Testing Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value & Volume
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Technique
  • 7.2.3. By Application
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3 Europe: Country Analysis
  • 7.3.1. France Antimicrobial Susceptibility Testing Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value & Volume
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Technique
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End User
  • 7.3.2. Germany Antimicrobial Susceptibility Testing Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value & Volume
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Technique
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Antimicrobial Susceptibility Testing Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value & Volume
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Technique
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Antimicrobial Susceptibility Testing Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value & Volume
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Technique
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Antimicrobial Susceptibility Testing Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value & Volume
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Technique
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End User

8. Asia-Pacific Antimicrobial Susceptibility Testing Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value & Volume
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Technique
  • 8.2.3. By Application
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Antimicrobial Susceptibility Testing Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value & Volume
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Technique
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End User
  • 8.3.2. India Antimicrobial Susceptibility Testing Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value & Volume
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Technique
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End User
  • 8.3.3. South Korea Antimicrobial Susceptibility Testing Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value & Volume
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Technique
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End User
  • 8.3.4. Japan Antimicrobial Susceptibility Testing Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value & Volume
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Technique
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Antimicrobial Susceptibility Testing Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value & Volume
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Technique
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End User

9. South America Antimicrobial Susceptibility Testing Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value & Volume
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Technique
  • 9.2.3. By Application
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Antimicrobial Susceptibility Testing Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value & Volume
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Technique
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End User
  • 9.3.2. Argentina Antimicrobial Susceptibility Testing Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value & Volume
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Technique
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End User
  • 9.3.3. Colombia Antimicrobial Susceptibility Testing Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value & Volume
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Technique
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End User

10. Middle East and Africa Antimicrobial Susceptibility Testing Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value & Volume
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Technique
  • 10.2.3. By Application
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Antimicrobial Susceptibility Testing Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value & Volume
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Technique
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End User
  • 10.3.2. Saudi Arabia Antimicrobial Susceptibility Testing Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value & Volume
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Technique
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End User
  • 10.3.3. UAE Antimicrobial Susceptibility Testing Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value & Volume
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Technique
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

13. PESTLE Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. Competitive Landscape

• 15.1. Business Overview
• 15.2. Company Snapshot
• 15.3. Products & Services
• 15.4. Financials (In case of listed companies)
• 15.5. Recent Developments
• 15.6. SWOT Analysis
  • 15.6.1. Bio-Rad Laboratories Inc.
  • 15.6.2. Thermo Fisher Scientific Inc.
  • 15.6.3. Danaher Corporation
  • 15.6.4. bioMerieux, Inc.
  • 15.6.5. Creative Diagnostics
  • 15.6.6. Hi-Media Laboratories Pvt. Ltd.
  • 15.6.7. PerkinElmer, Inc.
  • 15.6.8. ELITech Group SAS
  • 15.6.9. F. Hoffmann-La Roche Ltd.
  • 15.6.10. Accelerate Diagnostics, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer